G.D.O. Lowe

5.0k total citations · 2 hit papers
70 papers, 3.7k citations indexed

About

G.D.O. Lowe is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, G.D.O. Lowe has authored 70 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 19 papers in Cardiology and Cardiovascular Medicine and 16 papers in Epidemiology. Recurrent topics in G.D.O. Lowe's work include Blood properties and coagulation (19 papers), Adipokines, Inflammation, and Metabolic Diseases (13 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). G.D.O. Lowe is often cited by papers focused on Blood properties and coagulation (19 papers), Adipokines, Inflammation, and Metabolic Diseases (13 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). G.D.O. Lowe collaborates with scholars based in United Kingdom, United States and Australia. G.D.O. Lowe's co-authors include C.D. Forbes, Isobel D. Walker, Ian A. Greer, Peter Clark, L. Regan, Lindsay Robertson, Olívia Wu, Peter Langhorne, Sara Twaddle and A. Rumley and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and European Heart Journal.

In The Last Decade

G.D.O. Lowe

68 papers receiving 3.5k citations

Hit Papers

Thrombophilia in pregnancy: a systematic review 2005 2026 2012 2019 2005 2013 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.D.O. Lowe United Kingdom 26 1.1k 1.0k 786 690 609 70 3.7k
Pierre‐Yves Scarabin France 39 804 0.8× 1.1k 1.1× 832 1.1× 494 0.7× 407 0.7× 88 5.6k
Marilyn Johnston Canada 32 2.0k 1.9× 1.9k 1.9× 512 0.7× 425 0.6× 1.0k 1.7× 94 5.1k
James A. Kaye United States 38 1.1k 1.1× 348 0.3× 937 1.2× 595 0.9× 823 1.4× 169 5.3k
Johanna G. van der Bom Netherlands 57 6.4k 6.1× 1.5k 1.5× 587 0.7× 666 1.0× 1.3k 2.2× 319 10.4k
Angela Chetrit Israel 38 316 0.3× 517 0.5× 330 0.4× 341 0.5× 609 1.0× 131 4.3k
A. Evans France 35 431 0.4× 1.5k 1.5× 311 0.4× 495 0.7× 970 1.6× 68 4.5k
Thomas Philipp Germany 38 162 0.2× 2.0k 2.0× 537 0.7× 787 1.1× 1.7k 2.7× 178 6.1k
John Imeson United Kingdom 32 778 0.7× 999 1.0× 1.9k 2.4× 682 1.0× 925 1.5× 48 5.1k
Egil Arnesen Norway 33 230 0.2× 1.2k 1.2× 597 0.8× 478 0.7× 1.1k 1.8× 52 4.8k
Jaspal S. Kooner United Kingdom 35 251 0.2× 1.5k 1.4× 352 0.4× 528 0.8× 906 1.5× 93 4.3k

Countries citing papers authored by G.D.O. Lowe

Since Specialization
Citations

This map shows the geographic impact of G.D.O. Lowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.D.O. Lowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.D.O. Lowe more than expected).

Fields of papers citing papers by G.D.O. Lowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.D.O. Lowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.D.O. Lowe. The network helps show where G.D.O. Lowe may publish in the future.

Co-authorship network of co-authors of G.D.O. Lowe

This figure shows the co-authorship network connecting the top 25 collaborators of G.D.O. Lowe. A scholar is included among the top collaborators of G.D.O. Lowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.D.O. Lowe. G.D.O. Lowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stocks, Nigel, J M Sparrow, Roshni Patel, et al.. (2011). The prevalence and analysis of risk factors for age-related macular degeneration: 18-year follow-up data from the Speedwell eye study, United Kingdom. Eye. 25(6). 784–793. 22 indexed citations
2.
Wu, Olívia, Lindsay Robertson, Sara Twaddle, et al.. (2006). Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technology Assessment. 10(11). 1–110. 390 indexed citations
3.
Wannamethee, S. Goya, G.D.O. Lowe, A. G. Shaper, et al.. (2004). Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease. Diabetologia. 47(9). 1557–1565. 43 indexed citations
4.
Woodward, Mark, et al.. (2003). Contribution of contemporaneous risk factors to social inequality in coronary heart disease and death: Scottish Heart Health Cohort Study. Preventive Medicine. 36. 1 indexed citations
5.
Lowe, G.D.O., et al.. (2002). Classical and Emerging Risk Factors for Cardiovascular Disease. [Miscellaneous]. 1 indexed citations
6.
Norrie, John, A. Gaw, Jane B. Ford, et al.. (2002). C-reactive protein is an independent predictor of risk for the development of diabetes mellitus in the West of Scotland Coronary Prevention Study. 22(5). 12 indexed citations
7.
Forbes, C.D., et al.. (1999). Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist.. PubMed. 25 Suppl 2. 55–60. 12 indexed citations
8.
Price, Jackie F., Nizam Mamode, F.B. Smith, et al.. (1997). Haemostatic and rheological factors as predictors of restenosis following percutaneous transluminal angioplasty. European Journal of Vascular and Endovascular Surgery. 14(5). 392–398. 13 indexed citations
9.
Baird, J. D., M C Allison, J. D. Briggs, et al.. (1996). Long-Term Use of the Low Molecular Weight Heparin Tinzaparin in Haemodialysis. Pathophysiology of Haemostasis and Thrombosis. 26(2). 90–97. 21 indexed citations
12.
Lowe, G.D.O., et al.. (1993). Association of fibrinolytic tests with outcome of acute upper-gastrointestinal-tract bleeding. The Lancet. 341(8844). 518–521. 11 indexed citations
13.
MacRury, Sandra & G.D.O. Lowe. (1990). Blood Rheology in Diabetes Mellitus. Diabetic Medicine. 7(4). 285–291. 73 indexed citations
14.
Gatehouse, Stuart, et al.. (1989). Blood Viscosity and Hearing Levels in the Caerphilly Collaborative Heart Disease Study. Archives of Otolaryngology - Head and Neck Surgery. 115(10). 1227–1230. 21 indexed citations
15.
Lowe, G.D.O.. (1988). Anticoagulant drugs in the elderly: valuable in selected patients.. BMJ. 297(6658). 1260–1263. 7 indexed citations
16.
Belch, J. J. F., et al.. (1987). Comparison of Inhibitory Actions of Prostacyclin and a New Prostacyclin Analogue on the Aggregation of Human Platelet in Whole Blood. Pathophysiology of Haemostasis and Thrombosis. 17(3). 147–153. 14 indexed citations
17.
Lowe, G.D.O.. (1983). Vasodilators: minoxidil and drugs used in peripheral vascular and cerebral disorders.. BMJ. 286(6373). 1262–1264. 3 indexed citations
18.
Prentice, Archie, G.D.O. Lowe, & C.D. Forbes. (1982). Diagnosis and treatment of venous thromboembolism by consultants in Scotland.. BMJ. 285(6342). 630–632. 18 indexed citations
19.
Lowe, G.D.O., M. M. Drummond, Sebastian Reith, et al.. (1980). Blood viscosity in young male diabetics with and without retinopathy. Diabetologia. 18(5). 359–363. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026